CCL: W:Computational drug design blues
- From: Gary Breton <gbreton]"[berry.edu>
- Subject: CCL: W:Computational drug design blues
- Date: Wed, 14 Sep 2005 14:44:28 -0400
Sent to CCL by: Gary Breton [gbreton]"[berry.edu]
Speaking as an organic chemist I can tell you that the answer to your
question is probably no. There is no easy way to tell whether a given
compound is easy or difficult to synthesize other than to give it to a
medicinal or organic chemist that has experience in and knows synthesis.
For example, a compound with a nitro group at one position may be very easy
to synthesize, but move it over one carbon and suddenly you have a very
difficult system to synthesize. Any "simple" guidelines would
probably not
differentiate between the difficulty in synthesis of these types of isomers.
While there have been attempts at generating software to aid in
"deconstructing" molecules towards the goal of making planned
syntheses
easier, none of these (at least to my knowledge) is particular robust. I
have never heard of an organic chemist...or seen cited in a paper...the use
of such software to aid in a synthetic route. While there may be
exceptions, it certainly isn't the norm.
...and I don't say all this just for the sake of job security ;)
Gary W. Breton
Associate Professor
Hard-Working Organic Chemist
Department of Chemistry
Berry College
PO Box 495016
Mount Berry, GA 30149
> Sent to CCL by: "Sandeep Kumar" [kumarsan\a/jhu.edu]
> Dear CCLers:
>
> I need some advice about the drug discovery/design. Using structure based
> design, one could develope several potential small molecular
inhibitors/drugs
> for a given protein target. Many of these compounds may appear very
attractive
> as they satisfy all lipinski's rules and your requirements for
> selectivity/specificity and may even have desirable solubility/ADME
profiles.
> These days its possible to incorporate all these features right at the
> computational design stage. However, the organic synthesis of the compound
> still remains a bottleneck as it turns out that many of the designed
compounds
> are 'hard' to synthesize or may require many steps of synthesis. I was
> wondering if there are some simple guidelines in the form of literature or
> 'hands on' experience available which could tell the
computational/medicinal
> chemist whether a designed compound would be easy or hard to synthesize
before
> he/she talks to the organic chemist.
>
> All your responses are greatly appreciated.
>
> Yours sincerely
> Sandeep Kumar, Ph.D.
> Johns Hopkins University,
> Dept. of Biology,
> 106 Mudd Hall,
> 3400 N. Charles St.
> Baltimore, MD 21218.
> Phone: 410-516-8433
> Email: kumarsan]"[jhu.edu>
>